Protocol merck 318-00: A double-blind, placebo-controlled, randomized, parallel, clinical trial to study the effect of losartan potassium on endothelial dysfunction and insulin resistance in obese patients with impaired fasting glucose
Phase of Trial: Phase IV
Latest Information Update: 21 Feb 2013
At a glance
- Drugs Losartan (Primary)
- Indications Essential hypertension; Glucose intolerance; Insulin resistance
- Focus Pharmacodynamics
- 11 Jul 2012 Actual patient number changed from 153 to 53 as reported by ClinicalTrials.gov.
- 02 Feb 2009 Actual patient numbers (153) added as reported by ClinicalTrials.gov.
- 02 Feb 2009 Actual end date changed from Jul 2008 to Dec 2008 as reported by ClinicalTrials.gov.